Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Steps toward harmonization for clinical development of medicines in pediatric ulcerative colitis-a global scientific discussion, part 2: data extrapolation, trial design, and pharmacokinetics.

Sun H, Vesely R, Nelson RM, Taminiau J, Szitanyi P, Isaac M, Klein A, Uzu S, Griebel D, Mulberg AE; International Inflammatory Bowel Disease Working Group..

J Pediatr Gastroenterol Nutr. 2014 Jun;58(6):684-8. doi: 10.1097/MPG.0000000000000322.

PMID:
24866782
2.

Steps toward harmonization for clinical development of medicines in pediatric ulcerative colitis-a global scientific discussion, part 1: efficacy endpoints and disease outcome assessments.

Sun H, Vesely R, Taminiau J, Szitanyi P, Papadopoulos EJ, Isaac M, Klein A, Uzu S, Griebel D, Mulberg AE; International Inflammatory Bowel Disease Working Group..

J Pediatr Gastroenterol Nutr. 2014 Jun;58(6):679-83. doi: 10.1097/MPG.0000000000000306.

PMID:
24866781
3.

Alternate endpoints and clinical outcome assessments in pediatric ulcerative colitis registration trials.

Sun H, Lee JJ, Papadopoulos EJ, Lee CS, Nelson RM, Sachs HC, Rodriguez WJ, Mulberg AE.

J Pediatr Gastroenterol Nutr. 2014 Jan;58(1):12-7. doi: 10.1097/MPG.0000000000000186.

PMID:
24121142
4.

Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.

Chande N, McDonald JW, Macdonald JK.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006774. doi: 10.1002/14651858.CD006774.pub2. Review. Update in: Cochrane Database Syst Rev. 2010;(10):CD006774.

PMID:
18425969
5.

Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.

Chande N, McDonald JW, Macdonald JK, Wang JJ.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD006774. doi: 10.1002/14651858.CD006774.pub3. Review.

PMID:
20927749
6.

Cyclosporine A for induction of remission in severe ulcerative colitis.

Shibolet O, Regushevskaya E, Brezis M, Soares-Weiser K.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004277. Review.

PMID:
15674937
7.

A review of infliximab use in ulcerative colitis.

Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB.

Clin Ther. 2008 Feb;30(2):223-30. doi: 10.1016/j.clinthera.2008.02.014. Review.

PMID:
18343261
8.

Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.

North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.; Colitis Foundation of America., Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo PA.

J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74.

PMID:
17460505
9.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Review.

PMID:
18501566
10.

Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network.

Turner D, Koletzko S, Griffiths AM, Hyams J, Dubinsky M, de Ridder L, Escher J, Lionetti P, Cucchiara S, Lentze MJ, Koletzko B, van Rheenen P, Russell RK, Mack D, Veereman G, Vermeire S, Ruemmele F.

J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):183-7. doi: 10.1097/MPG.0000000000001024.

PMID:
26545204
12.

Methotrexate: a drug of the future in ulcerative colitis?

Carbonnel F.

Curr Drug Targets. 2011 Sep;12(10):1413-6. Review.

PMID:
21466494
13.

Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.

Regueiro M, Loftus EV Jr, Steinhart AH, Cohen RD.

Inflamm Bowel Dis. 2006 Oct;12(10):979-94.

PMID:
17012969
14.

Probiotics for induction of remission in ulcerative colitis.

Mallon P, McKay D, Kirk S, Gardiner K.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005573. Review.

PMID:
17943867
15.

Probiotics for maintenance of remission in ulcerative colitis.

Naidoo K, Gordon M, Fagbemi AO, Thomas AG, Akobeng AK.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD007443. doi: 10.1002/14651858.CD007443.pub2. Review.

PMID:
22161412
16.

Migraine therapeutics in adolescents: a systematic analysis and historic perspectives of triptan trials in adolescents.

Sun H, Bastings E, Temeck J, Smith PB, Men A, Tandon V, Murphy D, Rodriguez W.

JAMA Pediatr. 2013 Mar 1;167(3):243-9. doi: 10.1001/jamapediatrics.2013.872. Review.

PMID:
23359002
17.

A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis.

Su C, Lewis JD, Goldberg B, Brensinger C, Lichtenstein GR.

Gastroenterology. 2007 Feb;132(2):516-26. Review.

PMID:
17258720
18.

Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

Marshall JK, Thabane M, Steinhart AH, Newman JR, Anand A, Irvine EJ.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004118. doi: 10.1002/14651858.CD004118.pub2. Review.

PMID:
23152224
19.

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Sutherland L, Macdonald JK.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000543. Review. Update in: Cochrane Database Syst Rev. 2012;10:CD000543.

PMID:
16625536
Items per page

Supplemental Content

Support Center